In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical investigator financial disclosure final rule sets $25,000 payment, $50,000 equity threshold.

This article was originally published in The Gray Sheet

Executive Summary

FINANCIAL DISCLOSURE THRESHOLD FOR CLINICAL INVESTIGATORS RAISED TO $25,000 in a final rule published by FDA in the Feb. 2 Federal Register. In its 1994 proposal, the agency had suggested a significantly lower trigger of $5,000 ("The Gray Sheet" Sept. 26, 1994, p. 12).



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts